Page 1 of 31
@Beckman
CoulterTM Kit MSDS
Doc. ID: 477445-75: Rev. AA
Product Information
Protein Analysis Methods
Product Name
Development Kit
Doc. ID 477445-75 AA
Issued (year/month/day) 2003/08/07
Part Number 477445
Series Name: ProteomeLabļ£?
Components
Description
This Protein Analysis Methods Development Kit contains coated
tubes that are considered articles and thereby exempt from
MSDS requirements
Histamine Reference Marker
Protein Test Mix
Tricine Buffer, pH 8.0
Citrate Buffer, pH 3.0
Citrate/MES Buffer, pH 6.0
Orange G Reference Marker
Transport Information
Transportation of this product is not regulated under ICAO, IMDG, US DOT, European ADR or Canadian TDG.
ļ£?2003 Beckman Coulter, Inc.
Global MSDS ā? English
Page 2 of 31
@Beckman
CoulterTM MATERIAL SAFETY DATA SHEET
Section 1 Company and Product Identiļ¬cation
Histamine Reference
Product Name
Marker Protein Analysis Methods Development Kit
Doc. ID 477445-75 AA
Issued (year/month/day) 2003/08/07
Part Number Component of P/N 477445
Product Use Capillary Electrophoresis Reagents
Series Name ProteomeLabļ£?
Manufacturer Beckman Coulter, Inc.
4300 Harbor Blvd.
Fullerton, CA 92835-3100, U.S.A.
Ā¤
Distributor and Refer to attached list, Document ID: 472050, for local distributor and
Emergency Phone No. emergency phone numbers.
Section 2 Composition and Information on Ingredients
Hazardous Ingredients: Meets Hazardous Criteria:
Chemical Name CAS # % by wt. EU US OSHA WHMIS
<5%
Histamine, dihydrochloride 56-92-8 No Yes Yes
See Section 15 Regulatory Information for additional information on hazard classiļ¬cations.
Section 3 Hazards Identiļ¬cation
Emergency Overview
Colorless; Clear; Liquid; Odorless
Nonļ¬ammable aqueous solution.
Skin and eye irritant.
Harmful by inhalation and if swallowed.
Physical Hazards No physical hazards were determined from a review of available literature.
Potential Health Contact may cause irritation to the eyes, skin, and mucous membranes. Inhalation of
Effects Summary mists may cause mucous membrane and upper respiratory irritation.
See Section 11 Toxicological Information for more detailed health information.
Product Hazard EU: WHMIS: US OSHA:
Classiļ¬cations Not applicable D2A Hazardous
Beckman Coulter Safety Flammability (Section V): 0 Code
Rating Health (Section XI): 2 0=none
Reactivity with Water (Section X): 0 1=slight
Contact (Section VIII): 2 2=caution
3=severe
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 3 of 31
Histamine Reference Marker
Section 4 First Aid Measures
Inhalation If product is inhaled, move exposed individual to fresh air. If individual is not
breathing, begin artiļ¬cial respiration immediately and obtain medical attention.
Eye Contact If product enters eyes, wash eyes gently under running water for 15 minutes or
longer, making sure that the eyelids are held open. If pain or irritation occur, obtain
medical attention.
Skin Contact In case of skin contact, ļ¬ush with copious amounts of water for at least 15 minutes. If
pain or irritation occur, obtain medical attention.
Ingestion If ingested, wash mouth out with water. Contact local poison control center for
assistance. Seek medical attention immediately.
Section 5 Fire Fighting Measures
Flash Point Not applicable
Flammable Limits Not applicable
Autoignition Temp. Not applicable
Extinguishing Media Use extinguishing media suitable for surrounding ļ¬re.
Special Fire and None identiļ¬ed.
Explosion Hazards
Hazardous Combustion No combustion products posing signiļ¬cant hazards are expected from this product.
Products
Protective Equipment Self-contained breathing apparatus is recommended for ļ¬reļ¬ghters.
for Fireļ¬ghters
Section 6 Accidental Release Measures
Personal Precautions Eye protection and impervious gloves should be worn during spill clean-up.
Spill and Leak Contain spill and collect with inert absorbent and place in a suitable container for
Procedures disposal.
Environmental Contain spill to prevent migration.
Precautions
Section 7 Handling and Storage
Handling Precautions Use good laboratory procedures. Avoid contact with eyes, skin and clothing. Avoid
creating and breathing of mists.
Recommended Storage To maintain efļ¬cacy, store according to the instructions in the product labeling.
Conditions
Section 8 Exposure Controls and Personal Protection
Exposure Limits
US OSHA: None established
ACGIH: None established
DFG MAK: None established
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 4 of 31
Histamine Reference Marker
Section 8 Exposure Controls and Personal Protection (Continued)
Engineering Controls No special engineering controls are required. Use with good general ventilation.
Respiratory Protection Under normal conditions, the use of this product should not require respiratory
protection. If overexposure should occur and ventilation is not adequate to maintain
airborne concentrations at acceptable levels, the use of respiratory protection should
be evaluated by a qualiļ¬ed professional.
Eye Protection Safety glasses are recommended to prevent eye contact.
Skin Protection Impervious gloves are recommended to prevent repeated or prolonged skin contact.
Section 9 Physical and Chemical Properties
Physical State Liquid
Color Colorless
Transparency Clear
Odor Odorless
Odor Threshold Not applicable
pH Not available
Boiling Point 100Ā°C(212Ā°F)
Melting Point 0Ā°C(32Ā°F)
Speciļ¬c Gravity 1 @25Ā°C
Vapor Pressure 17.5 mmHg@20Ā°C
Vapor Density Not available
Evaporation Rate Not available
Solubility
Water Soluble
Organic Not available
Section 10 Stability and Reactivity
Stability Stable under normal temperatures and pressures.
Hazardous No hazardous incompatibilities were determined from a review of literature available.
Incompatibilities
Hazardous No information found.
Decomposition Products
Conditions to Avoid None identiļ¬ed.
Section 11 Toxicological Information
Toxicity Data
for Hazardous Ingredients
Histamine, dihydrochloride Oral LD50 Mouse: 2534 mg/kg
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 5 of 31
Histamine Reference Marker
Section 11 Toxicological Information (Continued)
Primary Routes The most likely routes of exposure are skin and eye contact. Inhalation may occur if
of Exposure mists are formed in product use.
Potential Effects of Eye and skin contact may cause moderate to severe irritation. Inhalation of mists may
Acute Exposure cause irritation to the mucous membranes and respiratory tract. Ingestion may cause
mucous membrane and gastrointestinal irritation with nausea, vomiting and abdominal
pain.
Potential Effects of None identiļ¬ed.
Chronic Exposure
Symptoms of Symptoms of contact include stinging sensation, redness, pain and swelling.
Overexposure Symptoms of inhalation exposure include cough, runny nose, difļ¬culty breathing,
shortness of breath and sore throat.
Carcinogenicity No ingredients in this product are listed as carcinogens by ACGIH, IARC, NTP, OSHA
or 67/548/EEC Annex I.
Other Effects None identiļ¬ed.
Conditions Aggravated None identiļ¬ed.
by Exposure
Section 12 Ecological Information
Ecotoxicity No information available.
Biodegradability No information available.
Mobility No information available.
Section 13 Disposal Considerations
Waste Disposal Dispose of waste product, unused product and contaminated packaging in compliance
with federal, state and local regulations. If unsure of the applicable requirements,
contact the authorities for information.
Section 14 Transport Information
Transportation of this product is not regulated under ICAO, IMDG, US DOT, European ADR or Canadian TDG.
Section 15 Regulatory Information
US Federal and State Regulations
SARA 313 No ingredients listed
CERCLA RGās, No ingredients listed
40 CFR 302.4
California Proposition 65 No ingredients listed
Massachusetts MSL No ingredients listed
New Jersey Dept. of No ingredients listed
Health RTK List
Pennsylvania RTK No ingredients listed
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 6 of 31
Histamine Reference Marker
Section 15 Regulatory Information (Continued)
EU Labeling Classiļ¬cation
Preparation not classiļ¬ed.
Canada
WHMIS Classiļ¬cation: D2AāPoisonous and Infections Material: Division 2āOther Toxic Effects: Very Toxic
(Chronic Toxic Effects)
PIN: Not applicable
Ingredients on Ingredient None
Disclosure List:
Ingredients with unknown None
toxicological properties:
Section 16 Other Information
For further information, please contact your local Beckman Coulter representative.
WHILE BECKMAN COULTER, INC. BELIEVES THE INFORMATION CONTAINED HEREIN IS VALID AND ACCURATE, BECKMAN COULTER MAKES NO WARRANTY OR
REPRESENTATION AS TO ITS VALIDITY, ACCURACY, OR CURRENCY. BECKMAN COULTER SHALL NOT BE LIABLE OR OTHERWISE RESPONSIBLE IN ANY WAY FOR USE
OF EITHER THIS INFORMATION OR MATERIALS TO WHICH IT APPLIES. DISPOSAL OF HAZARDOUS MATERIALS MAY BE SUBJECT TO LOCAL LAWS OR REGULATIONS.
Printed in U.S.A.
Page 7 of 31
@Beckman
CoulterTM MATERIAL SAFETY DATA SHEET
Section 1 Company and Product Identiļ¬cation
Protein Test Mix
Product Name Protein Analysis Methods Development Kit
Doc. ID 477445-75 AA
Issued (year/month/day) 2003/08/07
Part Number Component of P/N 477445
Product Use Capillary Electrophoresis Reagents
Series Name ProteomeLabļ£?
Manufacturer Beckman Coulter, Inc.
4300 Harbor Blvd.
Fullerton, CA 92835-3100, U.S.A.
Ā¤
Distributor and Refer to attached list, Document ID: 472050, for local distributor and
Emergency Phone No. emergency phone numbers.
Section 2 Composition and Information on Ingredients
Hazardous Ingredients: Meets Hazardous Criteria:
Chemical Name CAS # % by wt. EU US OSHA WHMIS
>25%
Ribonuclease A 9001-99-4 No Yes Yes
See Section 15 Regulatory Information for additional information on hazard classiļ¬cations.
Section 3 Hazards Identiļ¬cation
Emergency Overview
Medium brown; Opaque; Crystalline powder; Odorless
Negligible ļ¬re hazard when exposed to ļ¬ame or heat.
Potential sensitizer.
Physical Hazards No physical hazards were determined from a review of available literature.
Potential Health Exposure may result in irritation of skin, eyes, and mucous membranes.
Effects Summary
See Section 11 Toxicological Information for more detailed health information.
Product Hazard EU: WHMIS: US OSHA:
Classiļ¬cations Not applicable D2B Hazardous
Beckman Coulter Safety Flammability (Section V): 0 Code
Rating Health (Section XI): 2 0=none
Reactivity with Water (Section X): 0 1=slight
Contact (Section VIII): 2 2=caution
3=severe
Section 4 First Aid Measures
Inhalation If product is inhaled, move exposed individual to fresh air. If individual is not
breathing, begin artiļ¬cial respiration immediately and obtain medical attention.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 8 of 31
Protein Test Mix
Section 4 First Aid Measures (Continued)
Eye Contact If product enters eyes, wash eyes gently under running water for 15 minutes or
longer, making sure that the eyelids are held open. If pain or irritation occur, obtain
medical attention.
Skin Contact In case of skin contact, ļ¬ush with copious amounts of water for at least 15 minutes. If
pain or irritation occur, obtain medical attention.
Ingestion If ingested, wash mouth out with water. Contact local poison control center for
assistance. Seek medical attention immediately.
Section 5 Fire Fighting Measures
Flash Point Not available
Flammable Limits Not applicable
Autoignition Temp. Not available
Extinguishing Media Use extinguishing media suitable for surrounding ļ¬re.
Special Fire and No special hazards determined.
Explosion Hazards
Hazardous Combustion Due to the composition and volume of this product, combustion products generated
Products from it are not expected to present a signiļ¬cant hazard.
Protective Equipment Self-contained breathing apparatus is recommended for ļ¬reļ¬ghters.
for Fireļ¬ghters
Section 6 Accidental Release Measures
Personal Precautions Avoid skin contact. Use good laboratory procedures.
Spill and Leak Wipe up spill and place in container suitable for disposal.
Procedures
Environmental Contain spill to prevent migration.
Precautions
Section 7 Handling and Storage
Handling Precautions Avoid inhaling, ingesting, and contact with eyes and skin.
Recommended Storage Keep away from incompatible material.
Conditions To maintain efļ¬cacy, store according to the instructions in the product labeling.
Section 8 Exposure Controls and Personal Protection
Exposure Limits
US OSHA: None established
ACGIH: None established
DFG MAK: None established
Engineering Controls Use in well ventilated area.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 9 of 31
Protein Test Mix
Section 8 Exposure Controls and Personal Protection (Continued)
Respiratory Protection Under normal conditions, the use of this product should not require respiratory
protection. If overexposure should occur and ventilation is not adequate to maintain
airborne concentrations at acceptable levels, the use of respiratory protection should
be evaluated by a qualiļ¬ed professional.
Eye Protection Safety glasses should be worn to prevent eye contact.
Skin Protection Impervious gloves are recommended to prevent repeated or prolonged skin contact.
Section 9 Physical and Chemical Properties
Physical State Crystalline powder
Color Medium brown
Transparency Opaque
Odor Odorless
Odor Threshold Not applicable
pH Not applicable
Boiling Point Not applicable
Melting Point Not available
Speciļ¬c Gravity Not applicable
Vapor Pressure Not applicable
Vapor Density Not applicable
Evaporation Rate Not applicable
Solubility
Water Soluble
Organic Not available
Section 10 Stability and Reactivity
Stability Stable under normal temperatures and pressures.
Hazardous Strong oxidizers
Incompatibilities
Hazardous When stored as labeled, no known hazardous decomposition products are formed
Decomposition Products during the shelf-life of this product.
Conditions to Avoid Keep away from incompatible material.
Section 11 Toxicological Information
Toxicity Data Not applicable
for Hazardous Ingredients
Primary Routes The most likely routes of exposure are skin and eye contact.
of Exposure
Potential Effects of Contact with the skin or eyes may cause irritation.
Acute Exposure
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 10 of 31
Protein Test Mix
Section 11 Toxicological Information (Continued)
Potential Effects of None identiļ¬ed.
Chronic Exposure
Symptoms of None identiļ¬ed.
Overexposure
Carcinogenicity No ingredients in this product are listed as carcinogens by ACGIH, IARC, NTP, OSHA
or 67/548/EEC Annex I.
Other Effects None identiļ¬ed.
Conditions Aggravated None identiļ¬ed.
by Exposure
Section 12 Ecological Information
Ecotoxicity No information available.
Biodegradability No information available.
Mobility No information available.
Section 13 Disposal Considerations
Waste Disposal Dispose of waste product, unused product and contaminated packaging in compliance
with federal, state and local regulations. If unsure of the applicable requirements,
contact the authorities for information.
Section 14 Transport Information
Transportation of this product is not regulated under ICAO, IMDG, US DOT, European ADR or Canadian TDG.
Section 15 Regulatory Information
US Federal and State Regulations
SARA 313 No ingredients listed
CERCLA RGās, No ingredients listed
40 CFR 302.4
California Proposition 65 No ingredients listed
Massachusetts MSL No ingredients listed
New Jersey Dept. of No ingredients listed
Health RTK List
Pennsylvania RTK No ingredients listed
EU Labeling Classiļ¬cation
Preparation not classiļ¬ed.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 11 of 31
Protein Test Mix
Section 15 Regulatory Information (Continued)
Canada
WHMIS Classiļ¬cation: D2BāPoisonous and Infectious Material: Division 2āOther Toxic Effects: Toxic (Skin
Irritation)
D2BāPoisonous and Infectious Material: Division 2āOther Toxic Effects: Toxic (Eye
Irritation)
PIN: Not applicable
Ingredients on Ingredient None
Disclosure List:
Ingredients with unknown None
toxicological properties:
Section 16 Other Information
For further information, please contact your local Beckman Coulter representative.
WHILE BECKMAN COULTER, INC. BELIEVES THE INFORMATION CONTAINED HEREIN IS VALID AND ACCURATE, BECKMAN COULTER MAKES NO WARRANTY OR
REPRESENTATION AS TO ITS VALIDITY, ACCURACY, OR CURRENCY. BECKMAN COULTER SHALL NOT BE LIABLE OR OTHERWISE RESPONSIBLE IN ANY WAY FOR USE
OF EITHER THIS INFORMATION OR MATERIALS TO WHICH IT APPLIES. DISPOSAL OF HAZARDOUS MATERIALS MAY BE SUBJECT TO LOCAL LAWS OR REGULATIONS.
Printed in U.S.A.
Page 12 of 31
@Beckman
CoulterTM MATERIAL SAFETY DATA SHEET
Section 1 Company and Product Identiļ¬cation
Tricine Buffer, pH 8.0
Product Name
Protein Analysis Methods Development Kit
Doc. ID 477445-75 AA
Issued (year/month/day) 2003/08/07
Part Number Component of P/N 477445
Product Use Capillary Electrophoresis Reagents
Series Name ProteomeLabļ£?
Manufacturer Beckman Coulter, Inc.
4300 Harbor Blvd.
Fullerton, CA 92835-3100, U.S.A.
Ā¤
Distributor and Refer to attached list, Document ID: 472050, for local distributor and
Emergency Phone No. emergency phone numbers.
Section 2 Composition and Information on Ingredients
Hazardous Ingredients: None
Section 3 Hazards Identiļ¬cation
Emergency Overview
Colorless; Clear; Liquid; Odorless
Negligible ļ¬re hazard when exposed to ļ¬ame or heat.
Does not meet EU, OSHA or WHMIS criteria for hazardous materials.
Physical Hazards No physical hazards were determined from a review of available literature.
Potential Health This product does not meet EU, OSHA or WHMIS criteria for hazardous materials.
Effects Summary
Product Hazard EU: WHMIS: US OSHA:
Classiļ¬cations Not applicable Not applicable Not applicable
Beckman Coulter Safety Flammability (Section V): 0 Code
Rating Health (Section XI): 1 0=none
Reactivity with Water (Section X): 0 1=slight
Contact (Section VIII): 1 2=caution
3=severe
Section 4 First Aid Measures
Inhalation If product is inhaled, move exposed individual to fresh air. If individual is not
breathing, begin artiļ¬cial respiration immediately and obtain medical attention.
Eye Contact If product enters eyes, wash eyes gently under running water for 15 minutes or
longer, making sure that the eyelids are held open. If pain or irritation occur, obtain
medical attention.
Skin Contact In case of skin contact, ļ¬ush with copious amounts of water for at least 15 minutes. If
pain or irritation occur, obtain medical attention.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 13 of 31
Tricine Buffer, pH 8.0
Section 4 First Aid Measures (Continued)
Ingestion If ingested, wash mouth out with water. Contact local poison control center for
assistance. Seek medical attention immediately.
Section 5 Fire Fighting Measures
Flash Point Not applicable
Flammable Limits Not applicable
Autoignition Temp. Not applicable
Extinguishing Media Use extinguishing media suitable for surrounding ļ¬re.
Special Fire and No special hazards determined.
Explosion Hazards
Hazardous Combustion No combustion products posing signiļ¬cant hazards are expected from this product.
Products
Protective Equipment Self-contained breathing apparatus is recommended for ļ¬reļ¬ghters.
for Fireļ¬ghters
Section 6 Accidental Release Measures
Personal Precautions No special precautions are necessary. Use good laboratory procedures.
Spill and Leak Wipe up spill and place in container suitable for disposal.
Procedures
Environmental Contain spill to prevent migration.
Precautions
Section 7 Handling and Storage
Handling Precautions No special precautions are necessary; use good laboratory procedures.
Recommended Storage To maintain efļ¬cacy, store according to the instructions in the product labeling.
Conditions
Section 8 Exposure Controls and Personal Protection
Exposure Limits
US OSHA: None established
ACGIH: None established
DFG MAK: None established
Engineering Controls No special engineering controls are required. Use with good general ventilation.
Respiratory Protection Under normal conditions, the use of this product should not require respiratory
protection.
Eye Protection Safety glasses are recommended to prevent eye contact.
Skin Protection Impervious gloves, such as latex or equivalent, should be worn to prevent skin
contact.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 14 of 31
Tricine Buffer, pH 8.0
Section 9 Physical and Chemical Properties
Physical State Liquid
Color Colorless
Transparency Clear
Odor Odorless
Odor Threshold Not applicable
pH 8.0
Boiling Point 100Ā°C(212Ā°F)
Melting Point 0Ā°C(32Ā°F)
1ā?
Speciļ¬c Gravity
Vapor Pressure Not available
Vapor Density Not available
Evaporation Rate Not available
Solubility
Water Soluble
Organic Not available
Section 10 Stability and Reactivity
Stability Stable under normal temperatures and pressures.
Hazardous No hazardous incompatibilities were determined from a review of literature available.
Incompatibilities
Hazardous No decomposition products posing signiļ¬cant hazards would be expected from this
Decomposition Products product.
Conditions to Avoid None determined.
Section 11 Toxicological Information
Toxicity Data Not applicable
for Hazardous Ingredients
Primary Routes The most likely routes of exposure are skin and eye contact.
of Exposure
Potential Effects of None identiļ¬ed.
Acute Exposure
Potential Effects of None identiļ¬ed.
Chronic Exposure
Symptoms of None identiļ¬ed.
Overexposure
Carcinogenicity No ingredients in this product are listed as carcinogens by ACGIH, IARC, NTP, OSHA
or 67/548/EEC Annex I.
Other Effects None identiļ¬ed.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 15 of 31
Tricine Buffer, pH 8.0
Section 11 Toxicological Information (Continued)
Conditions Aggravated None identiļ¬ed.
by Exposure
Section 12 Ecological Information
Ecotoxicity No information available.
Biodegradability No information available.
Mobility No information available.
Section 13 Disposal Considerations
Waste Disposal Dispose of waste product, unused product and contaminated packaging in compliance
with federal, state and local regulations. If unsure of the applicable requirements,
contact the authorities for information.
Section 14 Transport Information
Transportation of this product is not regulated under ICAO, IMDG, US DOT, European ADR or Canadian TDG.
Section 15 Regulatory Information
US Federal and State Regulations
SARA 313 No ingredients listed
CERCLA RGās, No ingredients listed
40 CFR 302.4
California Proposition 65 No ingredients listed
Massachusetts MSL No ingredients listed
New Jersey Dept. of No ingredients listed
Health RTK List
Pennsylvania RTK No ingredients listed
EU Labeling Classiļ¬cation
Preparation not classiļ¬ed.
Canada
This product does not meet WHMIS criteria for hazardous materials.
PIN: Not applicable
Ingredients on Ingredient None
Disclosure List:
Ingredients with unknown None
toxicological properties:
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 16 of 31
Tricine Buffer, pH 8.0
Section 16 Other Information
For further information, please contact your local Beckman Coulter representative.
WHILE BECKMAN COULTER, INC. BELIEVES THE INFORMATION CONTAINED HEREIN IS VALID AND ACCURATE, BECKMAN COULTER MAKES NO WARRANTY OR
REPRESENTATION AS TO ITS VALIDITY, ACCURACY, OR CURRENCY. BECKMAN COULTER SHALL NOT BE LIABLE OR OTHERWISE RESPONSIBLE IN ANY WAY FOR USE
OF EITHER THIS INFORMATION OR MATERIALS TO WHICH IT APPLIES. DISPOSAL OF HAZARDOUS MATERIALS MAY BE SUBJECT TO LOCAL LAWS OR REGULATIONS.
Printed in U.S.A.
Page 17 of 31
@Beckman
CoulterTM MATERIAL SAFETY DATA SHEET
Section 1 Company and Product Identiļ¬cation
Citrate Buffer, pH 3.0
Product Name
Protein Analysis Methods Development Kit
Doc. ID 477445-75 AA
Issued (year/month/day) 2003/08/07
Part Number Component of P/N 477445
Product Use Capillary Electrophoresis Reagents
Series Name ProteomeLabļ£?
Manufacturer Beckman Coulter, Inc.
4300 Harbor Blvd.
Fullerton, CA 92835-3100, U.S.A.
Ā¤
Distributor and Refer to attached list, Document ID: 472050, for local distributor and
Emergency Phone No. emergency phone numbers.
Section 2 Composition and Information on Ingredients
Hazardous Ingredients: Meets Hazardous Criteria:
Chemical Name CAS # % by wt. EU US OSHA WHMIS
<15
Ethylene Glycol 107-21-1 No Yes Yes
See Section 15 Regulatory Information for additional information on hazard classiļ¬cations.
Section 3 Hazards Identiļ¬cation
Emergency Overview
Colorless; Clear; Liquid; Odorless
Negligible ļ¬re hazard when exposed to ļ¬ame or heat.
Skin, eye and respiratory tract irritant.
Physical Hazards No physical hazards were determined from a review of available literature.
Potential Health Contact may cause irritation to the eyes, skin, and mucous membranes. Inhalation of
Effects Summary mists may cause mucous membrane and upper respiratory irritation.
See Section 11 Toxicological Information for more detailed health information.
Product Hazard EU: WHMIS: US OSHA:
Classiļ¬cations Not applicable D2A Hazardous
Beckman Coulter Safety Flammability (Section V): 0 Code
Rating Health (Section XI): 2 0=none
Reactivity with Water (Section X): 0 1=slight
Contact (Section VIII): 2 2=caution
3=severe
Section 4 First Aid Measures
Inhalation If product is inhaled, move exposed individual to fresh air. If individual is not
breathing, begin artiļ¬cial respiration immediately and obtain medical attention.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 18 of 31
Citrate Buffer, pH 3.0
Section 4 First Aid Measures (Continued)
Eye Contact If product is splashed in eyes, wash eyes under gently running water for 15 minutes
or longer, making sure that the eyelids are held open. Obtain medical attention.
Skin Contact In case of skin contact, ļ¬ush with copious amounts of water for at least 15 minutes. If
pain or irritation occur, obtain medical attention.
Ingestion If ingested, wash mouth out with water. Contact local poison control center for
assistance. Seek medical attention immediately.
Section 5 Fire Fighting Measures
Flash Point Not applicable
Flammable Limits Not applicable
Autoignition Temp. Not applicable
Extinguishing Media Use extinguishing media suitable for surrounding ļ¬re.
Special Fire and None identiļ¬ed.
Explosion Hazards
Hazardous Combustion Combustion products may include oxides of carbon and nitrogen.
Products
Protective Equipment Self-contained breathing apparatus is recommended for ļ¬reļ¬ghters.
for Fireļ¬ghters
Section 6 Accidental Release Measures
Personal Precautions Use universal precautions during clean-up procedures. Avoid eye and skin contact.
Spill and Leak Wipe up spill and place in container suitable for disposal.
Procedures
Environmental Contain spill to prevent migration.
Precautions
Section 7 Handling and Storage
Handling Precautions Use good laboratory procedures. Avoid contact with eyes, skin and clothing. Avoid
creating and breathing of mists.
Recommended Storage Keep away from incompatible material.
Conditions To maintain efļ¬cacy, store according to the instructions in the product labeling.
Section 8 Exposure Controls and Personal Protection
Exposure Limits
US OSHA: None established
ACGIH:
Ethylene Glycol 100 mg/m3 Ceiling (aerosol only)
DFG MAK:
Ethylene Glycol 10 ppm MAK; 26 mg/m3 MAK; 20 ppm Peak; 52 mg/m3 Peak; danger of percutaneous
absorption
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 19 of 31
Citrate Buffer, pH 3.0
Section 8 Exposure Controls and Personal Protection (Continued)
Engineering Controls Use in well ventilated area.
Respiratory Protection Under normal conditions, the use of this product should not require respiratory
protection. If overexposure should occur and ventilation is not adequate to maintain
airborne concentrations at acceptable levels, the use of respiratory protection should
be evaluated by a qualiļ¬ed professional.
Eye Protection Safety glasses or chemical goggles should be worn to prevent eye contact.
Skin Protection Impervious gloves are recommended to prevent repeated or prolonged skin contact.
Section 9 Physical and Chemical Properties
Physical State Liquid
Color Colorless
Transparency Clear
Odor Odorless
Odor Threshold Not applicable
pH 3
Boiling Point 100Ā°C(212Ā°F)
Melting Point 0Ā°C(32Ā°F)
Speciļ¬c Gravity 1 @20Ā°C
Vapor Pressure Not available
Vapor Density Not available
Evaporation Rate Not available
Solubility
Water Miscible
Organic Not available
Section 10 Stability and Reactivity
Stability Stable under normal temperatures and pressures.
Hazardous Strong bases
Incompatibilities Strong oxidizers
Hazardous When stored as labeled, no known hazardous decomposition products are formed
Decomposition Products during the shelf-life of this product.
Conditions to Avoid Avoid contact with incompatible materials.
Section 11 Toxicological Information
Toxicity Data
for Hazardous Ingredients
Ethylene Glycol Inhalation LC50 Rat: 10876 mg/kg; Oral LD50 Rat: 4700 mg/kg; Oral LD50
Mouse: 5500 mg/kg; Dermal LD50 Rabbit: 9530 uL/kg
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 20 of 31
Citrate Buffer, pH 3.0
Section 11 Toxicological Information (Continued)
Primary Routes The most likely routes of exposure are skin and eye contact. Inhalation may occur if
of Exposure mists are formed in product use.
Potential Effects of Exposure to ethylene glycol may result in eye and respiratory tract irritation.
Acute Exposure Inhalation of mists and absorption through skin may cause central nervous system
depression. Ingestion may cause severe central nervous system depression, kidney
failure, heart failure or respiratory arrest.
Potential Effects of Prolonged or repeated exposure to ethylene glycol may result in mild irritation
Chronic Exposure and central nervous system depression; symptoms may include throat irritation,
drowsiness, headache and backache. Contact with skin and eyes may result in
dermatitis and conjunctivitis with red, scaly skin and inļ¬amed eyes. Animal studies
indicate repeated ingestion of small amounts can cause severe kidney damage.
Symptoms of Symptoms of overexposure may include: eye, skin, nose and throat irritation;
Overexposure headache, weakness, dizziness, confusion, nausea and vomiting. Severe cases
may exhibit difļ¬culty in breathing, irregular heartbeat, reddish colored skin,
unconsciousness, convulsions, coma and death. Symptoms may be delayed for
several hours after exposure.
Carcinogenicity No ingredients in this product are listed as carcinogens by ACGIH, IARC, NTP, OSHA
or 67/548/EEC Annex I.
Other Effects Reproductive effects have been reported in animal studies.
Conditions Aggravated Individuals with central nervous system, kidney, liver or pulmonary system disorders
by Exposure may ļ¬nd these conditions aggravated by exposure to this product.
Section 12 Ecological Information
Ecotoxicity Ethylene Glycol: 96 Hr LC50 rainbow trout: 41000 mg/L;96 Hr LC50 bluegill: 27500
mg/L;96 Hr LC50 goldļ¬sh:27500 mg/L
Biodegradability No information available.
Mobility No information available.
Section 13 Disposal Considerations
Waste Disposal Dispose of waste product, unused product and contaminated packaging in compliance
with federal, state and local regulations. If unsure of the applicable requirements,
contact the authorities for information.
Section 14 Transport Information
Transportation of this product is not regulated under ICAO, IMDG, US DOT, European ADR or Canadian TDG.
Section 15 Regulatory Information
US Federal and State Regulations
SARA 313 Ethylene Glycol is subject to reporting requirements of Section 313, Title III of SARA.
CERCLA RGās, Ethylene Glycol is listed.
40 CFR 302.4
California Proposition 65 No ingredients listed
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 21 of 31
Citrate Buffer, pH 3.0
Section 15 Regulatory Information (Continued)
US Federal and State Regulations
Massachusetts MSL Ethylene Glycol is listed.
New Jersey Dept. of Ethylene Glycol is listed.
Health RTK List
Pennsylvania RTK Ethylene Glycol is listed.
EU Labeling Classiļ¬cation
Preparation not classiļ¬ed.
Canada
WHMIS Classiļ¬cation: D2AāPoisonous and Infections Material: Division 2āOther Toxic Effects: Very Toxic
(Teratogenicity and Embryotoxicity)
D2AāPoisonous and Infections Material: Division 2āOther Toxic Effects: Very Toxic
(Chronic Toxic Effects)
PIN: Not applicable
Ingredients on Ingredient Citric Acid
Disclosure List: Ethylene Glycol
Ingredients with unknown None
toxicological properties:
Section 16 Other Information
For further information, please contact your local Beckman Coulter representative.
WHILE BECKMAN COULTER, INC. BELIEVES THE INFORMATION CONTAINED HEREIN IS VALID AND ACCURATE, BECKMAN COULTER MAKES NO WARRANTY OR
REPRESENTATION AS TO ITS VALIDITY, ACCURACY, OR CURRENCY. BECKMAN COULTER SHALL NOT BE LIABLE OR OTHERWISE RESPONSIBLE IN ANY WAY FOR USE
OF EITHER THIS INFORMATION OR MATERIALS TO WHICH IT APPLIES. DISPOSAL OF HAZARDOUS MATERIALS MAY BE SUBJECT TO LOCAL LAWS OR REGULATIONS.
Printed in U.S.A.
Page 22 of 31
@Beckman
CoulterTM MATERIAL SAFETY DATA SHEET
Section 1 Company and Product Identiļ¬cation
Citrate/MES Buffer, pH
Product Name
6.0 Protein Analysis Methods Development Kit
Doc. ID 477445-75 AA
Issued (year/month/day) 2003/08/07
Part Number Component of P/N 477445
Product Use Capillary Electrophoresis Reagents
Series Name ProteomeLabļ£?
Manufacturer Beckman Coulter, Inc.
4300 Harbor Blvd.
Fullerton, CA 92835-3100, U.S.A.
Ā¤
Distributor and Refer to attached list, Document ID: 472050, for local distributor and
Emergency Phone No. emergency phone numbers.
Section 2 Composition and Information on Ingredients
Hazardous Ingredients: Meets Hazardous Criteria:
Chemical Name CAS # % by wt. EU US OSHA WHMIS
<15%
Ethylene Glycol 107-21-1 No Yes Yes
See Section 15 Regulatory Information for additional information on hazard classiļ¬cations.
Section 3 Hazards Identiļ¬cation
Emergency Overview
Colorless; Clear; Liquid; Odorless
Negligible ļ¬re hazard when exposed to ļ¬ame or heat.
Skin, eye and respiratory tract irritant.
Physical Hazards No physical hazards were determined from a review of available literature.
Potential Health Contact may cause irritation to the eyes, skin, and mucous membranes. Inhalation of
Effects Summary mists may cause mucous membrane and upper respiratory irritation.
See Section 11 Toxicological Information for more detailed health information.
Product Hazard EU: WHMIS: US OSHA:
Classiļ¬cations Not applicable D2A Hazardous
Beckman Coulter Safety Flammability (Section V): 0 Code
Rating Health (Section XI): 2 0=none
Reactivity with Water (Section X): 0 1=slight
Contact (Section VIII): 2 2=caution
3=severe
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 23 of 31
Citrate/MES Buffer, pH 6.0
Section 4 First Aid Measures
Inhalation If product is inhaled, move exposed individual to fresh air. If individual is not
breathing, begin artiļ¬cial respiration immediately and obtain medical attention.
Eye Contact If product enters eyes, wash eyes gently under running water for 15 minutes or
longer, making sure that the eyelids are held open. If pain or irritation occur, obtain
medical attention.
Skin Contact In case of skin contact, ļ¬ush with copious amounts of water for at least 15 minutes. If
pain or irritation occur, obtain medical attention.
Ingestion If ingested, wash mouth out with water. Contact local poison control center for
assistance. Seek medical attention immediately.
Section 5 Fire Fighting Measures
Flash Point Not applicable
Flammable Limits Not applicable
Autoignition Temp. Not applicable
Extinguishing Media Use extinguishing media suitable for surrounding ļ¬re.
Special Fire and None identiļ¬ed.
Explosion Hazards
Hazardous Combustion Combustion products may include oxides of carbon and nitrogen.
Products
Protective Equipment Self-contained breathing apparatus is recommended for ļ¬reļ¬ghters.
for Fireļ¬ghters
Section 6 Accidental Release Measures
Personal Precautions Use universal precautions during clean-up procedures. Avoid eye and skin contact.
Spill and Leak Wipe up spill and place in container suitable for disposal.
Procedures
Environmental Contain spill to prevent migration.
Precautions
Section 7 Handling and Storage
Handling Precautions Use good laboratory procedures. Avoid contact with eyes, skin and clothing. Avoid
creating and breathing of mists.
Recommended Storage Keep away from incompatible material.
Conditions To maintain efļ¬cacy, store according to the instructions in the product labeling.
Section 8 Exposure Controls and Personal Protection
Exposure Limits
US OSHA: None established
ACGIH:
Ethylene Glycol 100 mg/m3 Ceiling (aerosol only)
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 24 of 31
Citrate/MES Buffer, pH 6.0
Section 8 Exposure Controls and Personal Protection (Continued)
DFG MAK:
Ethylene Glycol 10 ppm MAK; 26 mg/m3 MAK; 20 ppm Peak; 52 mg/m3 Peak; danger of percutaneous
absorption
Engineering Controls Use in well ventilated area.
Respiratory Protection Under normal conditions, the use of this product should not require respiratory
protection. If overexposure should occur and ventilation is not adequate to maintain
airborne concentrations at acceptable levels, the use of respiratory protection should
be evaluated by a qualiļ¬ed professional.
Eye Protection Safety glasses are recommended to prevent eye contact.
Skin Protection Impervious gloves are recommended to prevent repeated or prolonged skin contact.
Section 9 Physical and Chemical Properties
Physical State Liquid
Color Colorless
Transparency Clear
Odor Odorless
Odor Threshold Not applicable
pH 6.0
Boiling Point Not available
Melting Point Not available
Speciļ¬c Gravity Not available
Vapor Pressure Not available
Vapor Density Not available
Evaporation Rate Not available
Solubility
Water Soluble
Organic Not available
Section 10 Stability and Reactivity
Stability Stable under normal temperatures and pressures.
Hazardous Strong oxidizers
Incompatibilities
Hazardous When stored as labeled, no known hazardous decomposition products are formed
Decomposition Products during the shelf-life of this product.
Conditions to Avoid Avoid contact with incompatible materials.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 25 of 31
Citrate/MES Buffer, pH 6.0
Section 11 Toxicological Information
Toxicity Data
for Hazardous Ingredients
Ethylene Glycol Inhalation LC50 Rat: 10876 mg/kg; Oral LD50 Rat: 4700 mg/kg; Oral LD50
Mouse: 5500 mg/kg; Dermal LD50 Rabbit: 9530 uL/kg
Primary Routes The most likely routes of exposure are skin and eye contact. Inhalation may occur if
of Exposure mists are formed in product use.
Potential Effects of Exposure to ethylene glycol may result in eye and respiratory tract irritation.
Acute Exposure Inhalation of mists and absorption through skin may cause central nervous system
depression. Ingestion may cause severe central nervous system depression, kidney
failure, heart failure or respiratory arrest.
Potential Effects of Prolonged or repeated exposure to ethylene glycol may result in mild irritation
Chronic Exposure and central nervous system depression; symptoms may include throat irritation,
drowsiness, headache and backache. Contact with skin and eyes may result in
dermatitis and conjunctivitis with red, scaly skin and inļ¬amed eyes. Animal studies
indicate repeated ingestion of small amounts can cause severe kidney damage.
Symptoms of Symptoms of overexposure may include: eye, skin, nose and throat irritation;
Overexposure headache, weakness, dizziness, confusion, nausea and vomiting. Severe cases
may exhibit difļ¬culty in breathing, irregular heartbeat, reddish colored skin,
unconsciousness, convulsions, coma and death. Symptoms may be delayed for
several hours after exposure.
Carcinogenicity No ingredients in this product are listed as carcinogens by ACGIH, IARC, NTP, OSHA
or 67/548/EEC Annex I.
Other Effects Reproductive effects have been reported in animal studies.
Conditions Aggravated Individuals with central nervous system, cardiovascular, or kidney disorders may ļ¬nd
by Exposure these conditions aggravated by exposure to this product.
Section 12 Ecological Information
Ecotoxicity Ethylene Glycol: 96 Hr LC50 rainbow trout: 41000 mg/L;96 Hr LC50 bluegill: 27500
mg/L;96 Hr LC50 goldļ¬sh:27500 mg/L
Biodegradability No information available.
Mobility No information available.
Section 13 Disposal Considerations
Waste Disposal Dispose of waste product, unused product and contaminated packaging in compliance
with federal, state and local regulations. If unsure of the applicable requirements,
contact the authorities for information.
Section 14 Transport Information
Transportation of this product is not regulated under ICAO, IMDG, US DOT, European ADR or Canadian TDG.
Section 15 Regulatory Information
US Federal and State Regulations
SARA 313 Ethylene Glycol is subject to reporting requirements of Section 313, Title III of SARA.
CERCLA RGās, Ethylene Glycol is listed.
40 CFR 302.4
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 26 of 31
Citrate/MES Buffer, pH 6.0
Section 15 Regulatory Information (Continued)
US Federal and State Regulations
California Proposition 65 No ingredients listed
Massachusetts MSL Ethylene Glycol is listed.
New Jersey Dept. of Ethylene Glycol is listed.
Health RTK List
Pennsylvania RTK Ethylene Glycol is listed.
EU Labeling Classiļ¬cation
Preparation not classiļ¬ed.
Canada
WHMIS Classiļ¬cation: D2AāPoisonous and Infections Material: Division 2āOther Toxic Effects: Very Toxic
(Chronic Toxic Effects)
PIN: Not applicable
Ingredients on Ingredient Citric Acid
Disclosure List: Ethylene Glycol
Ingredients with unknown None
toxicological properties:
Section 16 Other Information
For further information, please contact your local Beckman Coulter representative.
WHILE BECKMAN COULTER, INC. BELIEVES THE INFORMATION CONTAINED HEREIN IS VALID AND ACCURATE, BECKMAN COULTER MAKES NO WARRANTY OR
REPRESENTATION AS TO ITS VALIDITY, ACCURACY, OR CURRENCY. BECKMAN COULTER SHALL NOT BE LIABLE OR OTHERWISE RESPONSIBLE IN ANY WAY FOR USE
OF EITHER THIS INFORMATION OR MATERIALS TO WHICH IT APPLIES. DISPOSAL OF HAZARDOUS MATERIALS MAY BE SUBJECT TO LOCAL LAWS OR REGULATIONS.
Printed in U.S.A.
Page 27 of 31
@Beckman
CoulterTM MATERIAL SAFETY DATA SHEET
Section 1 Company and Product Identiļ¬cation
Orange G Reference
Product Name
Marker Protein Analysis Methods Development Kit
Doc. ID 477445-75 AA
Issued (year/month/day) 2003/08/07
Part Number Component of P/N 477445
Product Use Capillary Electrophoresis Reagents
Series Name ProteomeLabļ£?
Manufacturer Beckman Coulter, Inc.
4300 Harbor Blvd.
Fullerton, CA 92835-3100, U.S.A.
Ā¤
Distributor and Refer to attached list, Document ID: 472050, for local distributor and
Emergency Phone No. emergency phone numbers.
Section 2 Composition and Information on Ingredients
Hazardous Ingredients: None
Section 3 Hazards Identiļ¬cation
Emergency Overview
Orange; Clear; Liquid; Odorless
Slight ļ¬re hazard when exposed to ļ¬ame or heat source.
Does not meet EU, OSHA or WHMIS criteria for hazardous materials.
Physical Hazards No physical hazards were determined from a review of available literature.
Potential Health This product does not meet EU, OSHA or WHMIS criteria for hazardous materials.
Effects Summary
Product Hazard EU: WHMIS: US OSHA:
Classiļ¬cations Not applicable Not applicable Not applicable
Beckman Coulter Safety Flammability (Section V): 1 Code
Rating Health (Section XI): 0 0=none
Reactivity with Water (Section X): 0 1=slight
Contact (Section VIII): 0 2=caution
3=severe
Section 4 First Aid Measures
Inhalation If product is inhaled, move exposed individual to fresh air. If individual is not
breathing, begin artiļ¬cial respiration immediately and obtain medical attention.
Eye Contact If product enters eyes, wash eyes gently under running water for 15 minutes or
longer, making sure that the eyelids are held open. If pain or irritation occur, obtain
medical attention.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 28 of 31
Orange G Reference Marker
Section 4 First Aid Measures (Continued)
Skin Contact In case of skin contact, ļ¬ush with copious amounts of water for at least 15 minutes. If
pain or irritation occur, obtain medical attention.
Ingestion If ingested, wash mouth out with water. Contact local poison control center for
assistance. Seek medical attention immediately.
Section 5 Fire Fighting Measures
Flash Point Not applicable
Flammable Limits Not applicable
Autoignition Temp. Not applicable
Extinguishing Media Use extinguishing media suitable for surrounding ļ¬re.
Special Fire and No special hazards determined.
Explosion Hazards
Hazardous Combustion No combustion products posing signiļ¬cant hazards are expected from this product.
Products
Protective Equipment Self-contained breathing apparatus is recommended for ļ¬reļ¬ghters.
for Fireļ¬ghters
Section 6 Accidental Release Measures
Personal Precautions No special precautions are necessary. Use good laboratory procedures.
Spill and Leak Wipe up spill and place in container suitable for disposal.
Procedures
Environmental Contain spill to prevent migration.
Precautions
Section 7 Handling and Storage
Handling Precautions No special precautions are necessary; use good laboratory procedures.
Recommended Storage Store at 2 to 8Ā°C
Conditions
Section 8 Exposure Controls and Personal Protection
Exposure Limits
US OSHA: None established
ACGIH: None established
DFG MAK: None established
Engineering Controls No special engineering controls are required. Use with good general ventilation.
Respiratory Protection Under normal conditions, the use of this product should not require respiratory
protection.
Eye Protection Safety glasses are recommended to prevent eye contact.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 29 of 31
Orange G Reference Marker
Section 8 Exposure Controls and Personal Protection (Continued)
Skin Protection Impervious gloves are recommended to prevent repeated or prolonged skin contact.
Section 9 Physical and Chemical Properties
Physical State Liquid
Color Orange
Transparency Clear
Odor Odorless
Odor Threshold Not applicable
pH 7
Boiling Point 100Ā°C(212Ā°F)
Melting Point 0Ā°C(32Ā°F)
1 ā@20Ā°C
Speciļ¬c Gravity
Vapor Pressure 760 mm Hg @25Ā°C
Vapor Density Not available
Evaporation Rate Not available
Solubility
Water Soluble
Organic Not available
Section 10 Stability and Reactivity
Stability Stable under normal temperatures and pressures.
Hazardous No hazardous incompatibilities were determined from a review of literature available.
Incompatibilities
Hazardous No decomposition products posing signiļ¬cant hazards would be expected from this
Decomposition Products product.
Conditions to Avoid None determined.
Section 11 Toxicological Information
Toxicity Data Not applicable
for Hazardous Ingredients
Primary Routes The most likely routes of exposure are skin and eye contact.
of Exposure
Potential Effects of None identiļ¬ed.
Acute Exposure
Potential Effects of None identiļ¬ed.
Chronic Exposure
Symptoms of None identiļ¬ed.
Overexposure
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 30 of 31
Orange G Reference Marker
Section 11 Toxicological Information (Continued)
Carcinogenicity No ingredients in this product are listed as carcinogens by ACGIH, IARC, NTP, OSHA
or 67/548/EEC Annex I.
Other Effects None identiļ¬ed.
Conditions Aggravated None identiļ¬ed.
by Exposure
Section 12 Ecological Information
Ecotoxicity No information available.
Biodegradability No information available.
Mobility No information available.
Section 13 Disposal Considerations
Waste Disposal Dispose of waste product, unused product and contaminated packaging in compliance
with federal, state and local regulations. If unsure of the applicable requirements,
contact the authorities for information.
Section 14 Transport Information
Transportation of this product is not regulated under ICAO, IMDG, US DOT, European ADR or Canadian TDG.
Section 15 Regulatory Information
US Federal and State Regulations
SARA 313 No ingredients listed
CERCLA RGās, No ingredients listed
40 CFR 302.4
California Proposition 65 No ingredients listed
Massachusetts MSL No ingredients listed
New Jersey Dept. of No ingredients listed
Health RTK List
Pennsylvania RTK No ingredients listed
EU Labeling Classiļ¬cation
Preparation not classiļ¬ed.
Protein Analysis Methods Development Kit Doc. ID: 477445-75 AA Page 31 of 31
Orange G Reference Marker
Section 15 Regulatory Information (Continued)
Canada
This product does not meet WHMIS criteria for hazardous materials.
PIN: Not applicable
Ingredients on Ingredient Orange G
Disclosure List:
Ingredients with unknown None
toxicological properties:
Section 16 Other Information
For further information, please contact your local Beckman Coulter representative.
WHILE BECKMAN COULTER, INC. BELIEVES THE INFORMATION CONTAINED HEREIN IS VALID AND ACCURATE, BECKMAN COULTER MAKES NO WARRANTY OR
REPRESENTATION AS TO ITS VALIDITY, ACCURACY, OR CURRENCY. BECKMAN COULTER SHALL NOT BE LIABLE OR OTHERWISE RESPONSIBLE IN ANY WAY FOR USE
OF EITHER THIS INFORMATION OR MATERIALS TO WHICH IT APPLIES. DISPOSAL OF HAZARDOUS MATERIALS MAY BE SUBJECT TO LOCAL LAWS OR REGULATIONS.
Printed in U.S.A.
|